Opus Genetics, Inc. Common Stock Shares Outstanding

• Opus Genetics, Inc. showed an increase of +121.4% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from Opus Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), Opus Genetics, Inc.'s Common Stock Shares Outstanding has declined by 17.0%.
• Historical annual values: Fiscal year 2025: 69.89 million shares | Fiscal year 2024: 31.57 million shares | Fiscal year 2023: 23.98 million shares | Fiscal year 2022: 20.86 million shares | Fiscal year 2021: 18.85 million shares | Fiscal year 2020: 10.88 million shares | Fiscal year 2019: 2.85 million shares | Fiscal year 2018: 3.12 million shares | Fiscal year 2017: 31.73 million shares | Fiscal year 2016: 23.74 million shares | Fiscal year 2015: 197.41 million shares | Fiscal year 2014: 178.25 million shares | Fiscal year 2013: 146.72 million shares | Fiscal year 2012: 119.43 million shares | Fiscal year 2011: 95.35 million shares | Fiscal year 2010: 84.16 million shares.
• Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: June 22, 2026